Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

卷 65, 期 9, 页码 2050-2052

OXFORD UNIV PRESS

mother to child transmission; drug plasma levels; HAART

Infectious Diseases Microbiology Pharmacology & Pharmacy